1. Anane R. [Childhood tuberculosis in Africa: epidemiologic, clinical and therapeutic aspects] Med.Trop.(Mars.) 2003;63(4-5):473-80.
2. Nejjari C, Filleul L, Zidouni N, Laid Y, Atek M, El Meziane A et al. Air pollution: a new respiratory risk for cities in low-income countries. Int.J.Tuberc.Lung Dis. 2003;7(3):223-31.
3. Khaldi F, Bouyahia O. Epidemiology of asthma in Maghrebian countries. Pediatr.Pulmonol. 2001;Suppl 23:30-1.
4. Yassaa N, Meklati BY, Cecinato A, Marino F. Organic aerosols in urban and waste landfill of Algiers metropolitan area: occurrence and sources. Environ.Sci.Technol. 2001;35(2):306-11.
5. Ait-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int.J.Tuberc.Lung Dis. 2000;4(3):268-71.
6. Khiati M, Mariche L. Treatment of childhood asthma in Algeria. Pediatr. Pulmonol.Suppl 1999;18:223-4.
7. Ould KF, Abdesslam T, Nemery B. Five-year follow-up of Algerian victims of the "Ardystil syndrome". Eur.Respir.J. 1999;13(4):940-1.
8. Cohen SG. Asthma among the famous. Adb el-Kader (1808-1883), founder of the Algerian state. Allergy Asthma Proc. 1997;18(1):50-2.
9. Ait-Khaled N, Hamadache M, Byles KB. Analysis of demand for pulmonary function testing for obstructive airway disease in an Algerian laboratory. Bull.Int.Union Tuberc.Lung Dis. 1990;65(1):39-41

1. Bottiger B, Palme IB, da Costa JL, Dias LF, Biberfeld G. Prevalence of HIV-1 and HIV-2/HTLV-IV infections in Luanda and Cabinda, Angola J.Acquir.Immune.Defic.Syndr. 1988;1(1):8-12.
2. da Silva MM. [Nursing's contribution in the fight against tuberculosis in Angola] Rev.Enferm. (Lisboa.) 1966;5(5):224-6.
3. Doveren RF. Why tuberculosis control in an unstable country is essential: desperate TB patients embrace DOTS in Angola Int.J.Tuberc.Lung Dis. 2001;5(5):486-8.
4. Eriksson B, Petrini B. [Mycobacterium marinum infection of the hand after a visit to the tropics] Lakartidningen 1989;86(37):3054-5.
5. FERREIRA EG. [Data collected by the first survey made in Angola to determine the extent of tuberculous infection.] An.Inst.Med.Trop.(Lisb.) 1953;10(3:1):1055-9.
6. Gerlach F. [Cutaneo-mucous diseases and pneumopathies caused by yeasts in Angola]. Dtsch.Med.J. 1960;11:402-6.
7. Gerlach F. [Yeast-fungi as pathogenic agents in Angola]. Wien.Med.Wochenschr. 1965;115(45):940-1.
8. Handschin D, Nuesch R. [32-year-old refugee from Angola with pulmonary coin lesion. Tuberculoma, pulmonary tuberculosis] Schweiz.Rundsch.Med.Prax. 2002;91(44):1872-4.
9. Harsch IA. [Diagnostic quiz. "Grippe" following visitors from Angola. Tuberculosis (primary complex)] MMW.Fortschr.Med. 2001;143(6):44-5.
10. Marta MJ, Oliveira A, Varela MG, Saavedra JA, Ravara L. Constrictive tuberculous pericarditis: case report and review of the literature Rev.Port.Cardiol. 2003;22(3):391-405.
11. Santos-Ferreira MO, Cohen T, Lourenco MH, Almeida MJ, Chamaret S, Montagnier L. A study of seroprevalence of HIV-1 and HIV-2 in six provinces of People's Republic of Angola: clues to the spread of HIV infection J.Acquir.Immune.Defic.Syndr. 1990;3(8):780-6.
12. Wolf B, Gama A, Rey L, Fonseca W, Roord J, Fleer A et al. Striking differences in the nasopharyngeal flora of healthy Angolan, Brazilian and Dutch children less than 5 years old. Ann.Trop.Paediatr. 1999;19(3):287-92.

1. Gathuru IM, Bunker CH, Ukoli FA, Egbagbe EE. Differences in rates of obstructive lung disease between Africans and African Americans. Ethn.Dis. 2002;12(4):S3-13.
2. Rowe AK, Onikpo F, Lama M, Cokou F, Deming MS. Management of childhood illness at health facilities in Benin: problems and their causes Am.J.Public Health 2001;91(10):1625-35.
3. Enarson DA. Resistance to antituberculosis medications: hard lessons to learn Arch. Intern.Med. 2000;160(5):581-2.
4. Aka NA, Allabi AC, Dreyfuss G, Kinde-Gazard D, Tawo L, Rondelaud D et al. [Epidemiological observations on the first case of human paragonimiasis and potential intermediate hosts of Paragonimus sp. in Benin] Bull.Soc.Pathol.Exot. 1999;92(3):191-4.
5. Trebucq A, Anagonou S, Gninafon M, Lambregts K, Boulahbal F. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy. Int.J.Tuberc.Lung Dis. 1999;3(6):466-70.
6. Rabasa AI, Okolo AA. Early diagnosis of septicaemia in infants with respiratory distress in the tropics. Trop.Doct. 1996;26(2):62-4.
7. Gninafon M, Lambregts-van Weezenbeek CS, Tawo L, Trebucq A. Ethambutol versus streptomycin during the hospitalized intensive phase of tuberculosis treatment in Benin Tuber.Lung Dis. 1995;76(4):373-4.
8. Adjovi C, Josse R, Foundohou J, Helynck B, Davo N. HIV seroprevalence rates in Benin AIDS 1994;8(7):1021-2.
9. Levy-Bruhl D, Soucat A, Diallo S, Lamarque JP, Ndiaye JM, Drame K et al. [Integration of the Expanded Program on Immunization into primary health care: examples of Benin and Guinea] Sante 1994;4(3):205-12.
10. Nwankwo MU, Okuonghae HO, Currier G, Schuit KE. Respiratory syncytial virus infections in malnourished children. Ann.Trop.Paediatr. 1994;14(2):125-30.
11. Obaseiki-Ebor EE, Akerele JO, Ebea PO. A survey of antibiotic outpatient prescribing and antibiotic self-medication J.Antimicrob.Chemother. 1987;20(5):759-63.
12. Azinge NO, Ghori SK, Ogah GO. A pointing sign for localization in early pneumonia Trop.Doct. 1981;11(2):50-1.

1. Rapid assessment of tuberculosis in a large prison system--Botswana, 2002 MMWR Morb.Mortal.Wkly.Rep. 2003;52(12):250-2.
2. Ansari NA, Kombe AH, Kenyon TA, Mazhani L, Binkin N, Tappero JW et al. Pathology and causes of death in a series of human immunodeficiency virus-positive and -negative pediatric referral hospital admissions in Botswana Pediatr.Infect.Dis.J. 2003;22(1):43-7.
3. Lockman S, Hone N, Kenyon TA, Mwasekaga M, Villauthapillai M, Creek T et al. Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana Int.J.Tuberc.Lung Dis. 2003;7(8):714-23.
4. Moalosi G, Floyd K, Phatshwane J, Moeti T, Binkin N, Kenyon T. Cost-effectiveness of home-based care versus hospital care for chronically ill tuberculosis patients, Francistown, Botswana Int.J.Tuberc.Lung Dis. 2003;7(9 Suppl 1):S80-S85.
5. Mosimaneotsile B, Talbot EA, Moeti TL, Hone NM, Moalosi G, Moffat HJ et al. Value of chest radiography in a tuberculosis prevention programme for HIV-infected people, Botswana Lancet 2003;362(9395):1551-2.
6. Alexander KA, Pleydell E, Williams MC, Lane EP, Nyange JF, Michel AL. Mycobacterium tuberculosis: an emerging disease of free-ranging wildlife Emerg.Infect.Dis. 2002;8(6):598-601.
7. Steen TW, Aruwa JE, Hone NM. The epidemiology of adult lung disease in Botswana. Int.J.Tuberc.Lung Dis. 2001;5(8):775-82.
8. White NW, Steen TW, Trapido AS, Davies JC, Mabongo NM, Monare N et al. Occupational lung diseases among former goldminers in two labour sending areas. S.Afr.Med.J. 2001;91(7):599-604.
9. Steen TW, Mabongo N, Moeti T, Monare B, Trapido AS. Former migrant mineworkers with respiratory disease: the South African compensation system, and implications for neighbouring countries. Cent.Afr.J.Med. 2000;46(1):18-22.
10. Huebner RE, Wasas A, Mushi A, Mazhani L, Klugman K. Nasopharyngeal carriage and antimicrobial resistance in isolates of Streptococcus pneumoniae and Haemophilus influenzae type b in children under 5 years of age in Botswana Int.J.Infect.Dis. 1998;3(1):18-25.
11. La Grange MA. Prevalence of occupational lung disease among Botswana men formerly employed in the South African mining industry. Occup.Environ.Med. 1998;55(8):577-8.
12. Cookson JB, Pilane CN, Tembo PM. Normal pulmonary function in Botswana Cent.Afr.J.Med. 1992;38(6):238-9. 13. Fox DH. Spirometry in healthy adult males in Botswana. Cent.Afr.J.Med. 1988;34(5):106-14.
13. Johnson RH. The cases of cancer seen at a Botswana hospital 1968-1972. Cent.Afr.J.Med. 1975;21(12):260-4.
14. Macrae SM, Cook BV. A retrospective study of the cancer patterns among hospital in-patients in Botswana 1960-72. Br.J.Cancer 1975;32(1):121-33.

1. Miningou SD, Zoubga AZ, Meda H, Meda N, Tiendrebeogo H. [Prevalence of asthma in subjects aged 15-64 years in Bobo-Dioulasso (Burkina Faso) in 1998]. Rev.Pneumol.Clin. 2002;58(6 Pt 1):341-5.
2. Ouoba K, Diara C, Dao MO, Ouedraogo I, Sanou I, Cisse R. Laryngo-tracheo-bronchial foreign bodies in children at the University Hospital Center of Ouagadougou (analysis of 96 cases) Med.Trop.(Mars.) 2002;62(6):611-4.
3. Ouedraogo M, Zigani A, Ouedraogo SM, Zoubga AZ, Birba E, Badoum G et al. Contribution of bronchial fibroscopy in pneumonology services in developing countries]. Rev.Mal Respir. 2001;18(3):297-300.
4. Wurthwein R, Gbangou A, Sauerborn R, Schmidt CM. Measuring the local burden of disease. A study of years of life lost in sub-Saharan Africa Int.J.Epidemiol. 2001;30(3):501-8.
5. Ait-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int.J.Tuberc.Lung Dis. 2000;4(3):268-71.
6. Ouedraogo A, Ouedraogo TL, Ouoba DE, Sawadogo JP. The current situation with regard to nicotine addiction in Burkina Faso: tobacco supply and data from the KAB-P survey of young people in Ouagadougou. Sante 2000;10(3):177-81.
7. Ouedraogo M, Ouedraogo SM, Diagbouga S, Coulibaly G, Achi V, Domoua K et al. Simultaneous resistance to rifampicin and isoniazid in patients with pulmonary tuberculosis. Rev.Mal Respir. 2000;17(2):477-80.
8. Diagbouga S, Fumoux F, Ledru E, Sanou PT, Barro D, Marchal G. Lack of direct correlation between CD4 T-lymphocyte counts and induration sizes of the tuberculin skin test in human immunodeficiency virus type 1 seropositive patients Int.J.Tuberc.Lung Dis. 1998;2(4):317-23.
9. Schutz R, Delclaux C, Balloul-Delclaux E, Pignol JP. [Treatment of empyema and pyopneumothorax of infectious origin and chronic evolution by drainage-lavage with iodized polyvinylpyrrolidone]. Rev.Mal Respir. 1992;9(3):313-7.
10. Lang T, Lafaix C, Fassin D, Arnaut I, Salmon B, Baudon D et al. Acute respiratory infections: a longitudinal study of 151 children in Burkina-Faso. Int.J.Epidemiol. 1986;15(4):553-60.

1. Buzingo T, Sanders M, Masabo JP, Nyandwi S, Van Deun A. Systematic restaining of sputum smears for quality control is useful in Burundi. Int.J.Tuberc.Lung Dis. 2003;7(5):439-44.
2. Rutta E, Kipingili R, Lukonge H, Assefa S, Mitsilale E, Rwechungura S. Treatment outcome among Rwandan and Burundian refugees with sputum smear-positive tuberculosis in Ngara, Tanzania. Int.J.Tuberc.Lung Dis. 2001;5(7):628-32.
3. Viau C, Hakizimana G, Bouchard M. Indoor exposure to polycyclic aromatic hydrocarbons and carbon monoxide in traditional houses in Burundi. Int.Arch.Occup.Environ.Health 2000;73(5):331-8.
4. Niyongabo T, Henzel D, Ndayishimyie JM, Melchior JC, Ndayiragije A, Ndihokubwayo JB et al. Nutritional status of adult inpatients in Bujumbura, Burundi (impact of HIV infection). Eur.J.Clin.Nutr. 1999;53(7):579-82.
5. Niyongabo T, Henzel D, Idi M, Nimubona S, Gikoro E, Melchior JC et al. Tuberculosis, human immunodeficiency virus infection, and malnutrition in Burundi. Nutrition 1999;15(4):289-93.
6. Di Perri G, Cazzadori A, Vento S, Allegranzi B, Nardi S, Brunello F et al. Tuberculosis among refugees and displaced people at the Burundi-Rwanda border. Clin.Infect.Dis. 1998;26(2):500-1.
7. Mlika-Cabanne N, Brauner M, Kamanfu G, Grenier P, Nikoyagize E, Aubry P et al. Radiographic abnormalities in tuberculosis and risk of coexisting human immunodeficiency virus infection. Methods and preliminary results from Bujumbura, Burundi. Am.J.Respir.Crit Care Med. 1995;152(2):794-9.
8. Kamanfu G, Mlika-Cabanne N, Girard PM, Nimubona S, Mpfizi B, Cishako A et al. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am.Rev.Respir.Dis. 1993;147(3):658-63.
9. Clumeck N, Sonnet J, Taelman H, Mascart-Lemone F, De Bruyere M, Vandeperre P et al. Acquired immunodeficiency syndrome in African patients. N.Engl.J.Med. 1984;310(8):492-7. Full listing

1. Noeske J, Kuaban C, Cunin P. Are smear-positive pulmonary tuberculosis patients a 'sentinel' population for the HIV epidemic in Cameroon?. Int.J.Tuberc.Lung Dis. 2004;8(3):346-51.
2. Jobin W. Health and equity impacts of a large oil project in Africa. Bull.World Health Organ 2003;81(6):420-6.
3. Moyou-Somo R, Kefie-Arrey C, Dreyfuss G, Dumas M. An epidemiological study of pleuropulmonary paragonimiasis among pupils in the peri-urban zone of Kumba town, Meme Division, Cameroon. BMC.Public Health 2003;3(1):40.
4. Niobe-Eyangoh SN, Kuaban C, Sorlin P, Cunin P, Thonnon J, Sola C et al. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J.Clin.Microbiol. 2003;41(6):2547-53.
5. Holtedahl K, Hurum H. Cross-sectional study of morbidity, morbidity-associated factors and cost of treatment in Ngaoundere, Cameroon, with implications for health policy in developing countries and development assistance policy. BMC.Int.Health Hum.Rights. 2002;2(1):2.
6. Kingue S, Tagny-Zukam D, Binam F, Nouedoui C, Teyang A, Muna WF. [Venous thromboembolism in Cameroon (report of 18 cases)]. Med.Trop.(Mars.) 2002;62(1):47-50.
7. Mwinga A. Drug-resistant tuberculosis in Africa. Ann.N.Y.Acad.Sci. 2001;953:106-12.
8. Brennan CA, Hackett J, Jr., Zekeng L, Lund JK, Vallari AS, Hickman RK et al. Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa. AIDS Res.Hum.Retroviruses 1997;13(10):901-4.
9. Sirol J, Kerfelec J, Papinutto JP. [Pulmonary paragonimiasis in Africa. Apropos of 26 cases collected in Western Cameroon. I. Statement of the parasitologic, anatomopathologic, epidemiologic and clinical facts]. Bull.Soc.Pathol.Exot.Filiales. 1967;60(6):533-43.

1. Morais dA, Gaspar A, Rosado PJ. Epidemiology of asthma in Portugal, Cape Verde, and Macao. Pediatr.Pulmonol. 2001;Suppl 23:35-7.
2. de Almeida MM, Pinto JR. Bronchial asthma in children: clinical and epidemiologic approach in different Portuguese speaking countries. Pediatr.Pulmonol.Suppl 1999;18:49-53.
3. Pinto JE. I.S.A.A.C. World Project: epidemiology in the Cape Verde and Madeira Islands. J.Investig.Allergol.Clin.Immunol. 1997;7(5):292-3.

1. Kassa-Kelembho E, Bobossi-Serengbe G, Takeng EC, Nambea-Koisse TB, Yapou F, Talarmin A. Surveillance of drug-resistant childhood tuberculosis in Bangui, Central African Republic. Int.J.Tuberc.Lung Dis. 2004;8(5):574-8.
2. Kassa-Kelembho E, Mbolidi CD, Service YB, Morvan J, Minssart P. Bacteremia in adults admitted to the Department of Medicine of Bangui Community Hospital (Central African Republic). Acta Trop. 2003;89(1):67-72.
3. Breton G, Service YB, Kassa-Kelembho E, Mbolidi CD, Minssart P. [Tuberculosis and HIV in Bangui, Central African Republic: strong prevalence and management difficulties]. Med.Trop.(Mars.) 2002;62(6):623-6.
4. Pepin J, Demers AM, Mberyo-Yaah F, Jaffar S, Blais C, Somse P et al. Acute lower respiratory infections among children hospitalized in Bangui, Central African Republic: toward a new case-management algorithm. Trans.R.Soc.Trop.Med.Hyg. 2001;95(4):410-7.
5. Demers AM, Morency P, Mberyo-Yaah F, Jaffar S, Blais C, Somse P et al. Risk factors for mortality among children hospitalized because of acute respiratory infections in Bangui, Central African Republic. Pediatr.Infect.Dis.J. 2000;19(5):424-32.
6. Rowe AK, Deming MS, Schwartz B, Wasas A, Rolka D, Rolka H et al. Antimicrobial resistance of nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae from children in the Central African Republic. Pediatr.Infect.Dis.J. 2000;19(5):438-44.
7. From the Centers for Disease Control and Prevention. Antibiotic resistance among nasopharyngeal isolates of Streptococcus pneumoniae and Haemophilus influenzae--Bangui, 1995. JAMA 1997;277(8):621.
8. Garin B, Glaziou P, Kassa-Kelembho E, Yassibanda S, Mbelesso P, Morvan J. High mortality rates among patients with tuberculosis in Bangui, Central African Republic. Lancet 1997;350(9087):1298.
9. Garin B, Di Costanzo B, Kassa KE, Legot B, Guerin D, Ouapou-Lena F et al. Drug-resistant Mycobacterium tuberculosis strains in tuberculosis inpatients in Bangui, Central African Republic. AIDS 1995;9(2):213-4.

1. Martin A, Baptiste JP, Krieger G. Respiratory infections: SARS and tuberculosis. Clin.Occup.Environ.Med. 2004;4(1):189-204.
2. Utzinger J, Wyss K, Moto DD, Tanner M, Singer BH. Community health outreach program of the Chad-Cameroon petroleum development and pipeline project. Clin.Occup.Environ.Med. 2004;4(1):9-26.
3. Tosi CH, Ngangro MN, Djimadoum N, Richard V. [Study of HIV seroprevalence in patients with pulmonary tuberculosis in 1999 in Chad]. Med.Trop.(Mars.) 2002;62(6):627-33.
4. Renaudin P. [Evaluation of the nutritional status of children less than 5 years of age in Moundou, Chad: correlations with morbidity and hospital mortality]. Med.Trop.(Mars.) 1997;57(1):49-54.
5. Leonard L. Cigarette smoking and perceptions about smoking and health in Chad. East Afr.Med.J. 1996;73(8):509-12.
6. Clumeck N, Sonnet J, Taelman H, Mascart-Lemone F, De Bruyere M, Vandeperre P et al. Acquired immunodeficiency syndrome in African patients. N.Engl.J.Med. 1984;310(8):492-7.
7. Markwalder K. Left-side pleuropulmonary amoebiasis: a case report from Chad. Trans.R.Soc.Trop.Med.Hyg. 1981;75(2):308-9.
8. Perpezat A, Destombes P, Mariat F. [Histopathologic study of nocardiosis in oxen in Chad and biochemical characteristics of Nocardia farcinica]. Rev.Elev.Med.Vet.Pays Trop. 1967;20(3):429-35.

Full listing

1. Gullstrom M, de la Torre CM, Bandeira S, Bjork M, Dahlberg M, Kautsky N et al. Seagrass ecosystems in the Western Indian Ocean. Ambio. 2002;31(7-8):588-96.
2. Toyb M, Lombart JP, Binti AA, Oumadi A, Molines C, Josse R. [AIDS and HIV infection in the Federal Islamic Republic of Comores (1988-1995)]. Med.Trop.(Mars.) 1997;57(1):59-61.
3. Feyaerts P, Thaoubani D, Aboubacar O, Molines C, Josse R. [Tuberculosis in the Federal Islamic Republic of Comores in 1995]. Med.Trop.(Mars.) 1996;56(3):303-7.

1. Botros BA, Sobh M, Wierzba T, Arthur RR, Mohareb EW, Frenck R et al. Prevalence of hantavirus antibody in patients with chronic renal disease in Egypt. Trans.R.Soc.Trop.Med.Hyg. 2004;98(6):331-6.
2. Cowgill KD, Loffredo CA, Eissa SA, Mokhtar N, Abdel-Hamid M, Fahmy A et al. Case-control study of non-Hodgkin's lymphoma and hepatitis C virus infection in Egypt. Int.J.Epidemiol. 2004.
3. El Banhawy OA, Ael SE-D, Amer T. Endoscopic-assisted midfacial degloving approach for type III juvenile angiofibroma. Int.J.Pediatr.Otorhinolaryngol. 2004;68(1):21-8.
4. El Dars FM, Mohamed AM, Aly HA. Monitoring ambient sulfur dioxide levels at some residential environments in the Greater Cairo urban Region--Egypt. Environ.Monit.Assess. 2004;95(1-3):269-86.
5. El Karaksy H, el Shabrawi M, Mohsen N, Kotb M, el Koofy N, el Deeb N. Capillaria philippinensis: a cause of fatal diarrhea in one of two infected Egyptian sisters. J.Trop.Pediatr. 2004;50(1):57-60.
6. el Sobky E, Mangoud AM, Mahrous S, Eissa MH, Sabee EI, Ibrahem IA et al. Molecular cytogentic profiles of hepatitis C infection in patients at Sharkia Governorate, Egypt. J.Egypt.Soc.Parasitol. 2004;34(1 Suppl):401-15.
7. Gutierrez MI, Siraj AK, Khaled H, Koon N, El Rifai W, Bhatia K. CpG island methylation in Schistosoma- and non-Schistosoma-associated bladder cancer. Mod.Pathol. 2004.
8. Hegab AE, Sakamoto T, Uchida Y, Nomura A, Ishii Y, Morishima Y et al. CLCA1 gene polymorphisms in chronic obstructive pulmonary disease. J.Med.Genet. 2004;41(3):e27.
9. Hifnawy MS, Mangoud AM, Eissa MH, Nor EE, Mostafa Y, Abouel-Magd Y et al. The role of aflatoxin-contaminated food materials and HCV in developing hepatocellular carcinoma in Al-Sharkia Governorate, Egypt. J.Egypt.Soc.Parasitol. 2004;34(1 Suppl):479-88.
10. Khater AE. Polonium-210 budget in cigarettes. J.Environ.Radioact. 2004;71(1):33-41.

1. Tudo G, Gonzalez J, Obama R, Rodriguez JM, Franco JR, Espasa M et al. Study of resistance to anti-tuberculosis drugs in five districts of Equatorial Guinea: rates, risk factors, genotyping of gene mutations and molecular epidemiology. Int.J.Tuberc.Lung Dis. 2004;8(1):15-22.
2. Brennan CA, Hackett J, Jr., Zekeng L, Lund JK, Vallari AS, Hickman RK et al. Sequence of gp41env immunodominant region of HIV type 1 group O from west central Africa. AIDS Res.Hum.Retroviruses 1997;13(10):901-4.
3. Romero M, Jr., Sanchez DE, Tejedor MN, Gil MJ. [Acute thoracic syndrome]. Sangre (Barc.) 1994;39(4):293-5.
4. Ananos G, Trilla A, Graus F, Mas J, Corachan M, Soriano E. [Paragonimiasis and pulmonary tuberculosis]. Med.Clin.(Barc.) 1992;98(7):257-9.
5. Simarro PP, Alamo A, Sima FO, Roche J, Mir M, Ndong P. Endemic human paragonimiasis in Equatorial Guinea. Detection of the existence of endemic human paragonimiasis in Equatorial Guinea as a result of an integrated sanitary programme. Trop.Geogr.Med. 1991;43(3):326-8.

1. Cangelosi GA, Freeman RJ, Lewis KN, Livingston-Rosanoff D, Shah KS, Milan SJ et al. Evaluation of a high-throughput repetitive-sequence-based PCR system for DNA fingerprinting of Mycobacterium tuberculosis and Mycobacterium avium complex strains. J.Clin.Microbiol. 2004;42(6):2685-93.
2. van Hest NA, de Vries G, van Gerven PJ, Baars HW. [Delay in the diagnosis of tuberculosis]. Ned.Tijdschr.Geneeskd. 2003;147(38):1825-9.
3. Increase in African immigrants and refugees with tuberculosis--Seattle-King County, Washington, 1998-2001. MMWR Morb.Mortal.Wkly.Rep. 2002;51(39):882-3.
4. Gibson NE, Boonstra O, Roukema R, Van der HS. Humanitarian assistance in UN operations: laboratory and consultative support of a local hospital in Eritrea. Mil.Med. 2002;167(8):653-6.
5. Houshaymi B, Tekleghiorghis T, Wilsmore AJ, Miles RJ, Nicholas RA. Investigations of outbreaks of contagious caprine pleuropneumonia in Eritrea. Trop.Anim Health Prod. 2002;34(5):383-9.
6. Omer MK, Skjerve E, Woldehiwet Z, Holstad G. A cross-sectional study of bovine tuberculosis in dairy farms in Asmara, Eritrea. Trop.Anim Health Prod. 2001;33(4):295-303.
7. Sato GH, Ghezae T, Negassi S. The Manzanar Project: towards a solution to poverty, hunger, environmental pollution, and global warming through sea water aquaculture and silviculture in deserts. In Vitro Cell Dev.Biol.Anim 1998;34(7):509-11.

1. Ganga-Zandzou PS, Nguema EK, Baite A, Boukaidi O, Megnier-Mbo MO, Ondimba EL. [Respiratory diseases in the Gabonese neonate]. Arch.Pediatr. 2004;11(4):374-5.
2. Loembe PM, Mwanyombet-Ompounga L, Assengone-Zeh Y, Kengue-Lechiombeka PR. [Early anterolateral surgery for tuberculosis of the lower cervical spine with neurological complications in adult. Our experience in Gabon]. Neurochirurgie 2000;46(6):541-8.
3. Okome-Nkoumou M, Mbounja-Loclo ME, Kombila M. [Spectrum of opportunistic infections in subjects infected with HIV at Libreville, Gabon]. Sante 2000;10(5):329-37.
4. Nze-Nguema F, Sankaranarayanan R, Barthelemy M, Nguizi-Ogoula S, Whelan S, Minko-Mi-Etoua D. Cancer in Gabon, 1984-1993: a pathology registry based relative frequency study. Bull.Cancer 1996;83(9):693-6.
5. Vuong PN, Bayssade-Dufour C, Mabika B, Ogoula-Gerbeix S, Kombila M. [Paragonimus westermani pulmonary distomatosis in Gabon. First case]. Presse Med. 1996;25(23):1084-5.
6. Voelker J, Sachs R. Morphology of the lung fluke Paragonimus uterobilateralis occurring in Gabon, West Africa. Trop.Med.Parasitol. 1985;36(4):210-2.
7. Denues AR, Munz W. Malignancies. At the Hospital of Doctor Albert Schweitzer, Lambarene, Gabon, 1950-1965. Int.J.Cancer 1967;2(4):406-11.

1. Gustafson P, Gomes VF, Vieira CS, Rabna P, Seng R, Johansson P et al. Tuberculosis in Bissau: incidence and risk factors in an urban community in sub-Saharan Africa. Int.J.Epidemiol. 2004;33(1):163-72.
2. Koivula T, Ekman M, Leitner T, Lofdahl S, Ghebremicahel S, Mostowy S et al. Genetic characterization of the Guinea-Bissau family of Mycobacterium tuberculosis complex strains. Microbes.Infect. 2004;6(3):272-8.
3. Rosado-Pinto J, Morais-Almeida M. Asthma in developing worlds. Pediatr.Pulmonol.Suppl 2004;26:66-8.
4. Seng R, Gustafson P, Gomes VF, Vieira CS, Rabna P, Larsen O et al. Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis. AIDS 2002;16(7):1059-66.
5. Stensballe LG, Trautner S, Kofoed PE, Nante E, Hedegaard K, Jensen IP et al. Comparison of nasopharyngeal aspirate and nasal swab specimens for detection of respiratory syncytial virus in different settings in a developing country. Trop.Med.Int.Health 2002;7(4):317-21.
6. Gustafson P, Gomes VF, Vieira CS, Jensen H, Seng R, Norberg R et al. Tuberculosis mortality during a civil war in Guinea-Bissau. JAMA 2001;286(5):599-603.
7. Andreasson PA, Dias F, Naucler A, Andersson S, Biberfeld G. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 1993;7(7):989-93.
8. Morgan G, Wilkins HA, Pepin J, Jobe O, Brewster D, Whittle H. AIDS following mother-to-child transmission of HIV-2. AIDS 1990;4(9):879-82.
9. Stavinoha V. [Tracheotomy in Conakry, Guinea--Equatorial Africa]. Cas.Lek.Cesk. 1968;107(44):1333-5.

1. Wiktor SZ, Abouya L, Angoran H, McFarland J, Sassan-Morokro M, Tossou O et al. Effect of an HIV counseling and testing program on AIDS-related knowledge and practices in tuberculosis clinics in Abidjan, Cote d'Ivoire. Int.J.Tuberc.Lung Dis. 2004;8(4):445-50.
2. Anglaret X, Messou E, Ouassa T, Toure S, Dakoury-Dogbo N, Combe P et al. Pattern of bacterial diseases in a cohort of HIV-1 infected adults receiving cotrimoxazole prophylaxis in Abidjan, Cote d'Ivoire. AIDS 2003;17(4):575-84.
3. Dick FA, Aka J. Lower respiratory tract infection in Sub-Saharan Africa: epidemiology, diagnostic, and therapeutic strategy. Pediatr.Pulmonol. 2001;Suppl 23:151-2.
4. Grant AD, Kaplan JE, De Cock KM. Preventing opportunistic infections among human immunodeficiency virus-infected adults in African countries. Am.J.Trop.Med.Hyg. 2001;65(6):810-21.
5. Ait-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int.J.Tuberc.Lung Dis. 2000;4(3):268-71.
6. Wiktor SZ, Sassan-Morokro M, Grant AD, Abouya L, Karon JM, Maurice C et al. Efficacy of trimethoprim-sulphamethoxazole prophylaxis to decrease morbidity and mortality in HIV-1-infected patients with tuberculosis in Abidjan, Cote d'Ivoire: a randomised controlled trial. Lancet 1999;353(9163):1469-75.
7. Lucas SB, Peacock CS, Hounnou A, Brattegaard K, Koffi K, Honde M et al. Disease in children infected with HIV in Abidjan, Cote d'Ivoire. BMJ 1996;312(7027):335-8.
8. Ackah AN, Coulibaly D, Digbeu H, Diallo K, Vetter KM, Coulibaly IM et al. Response to treatment, mortality, and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Cote d'Ivoire. Lancet 1995;345(8950):607-10.
9. Domoua K, N'Dhatz M, Coulibaly G, Traore F, Konan JB, Lucas S et al. [Autopsy findings in 70 AIDS patients who died in a department of pneumology in Ivory Coast: impact of tuberculosis]. Med.Trop.(Mars.) 1995;55(3):252-4.
10. Greenberg AE, Lucas S, Tossou O, Coulibaly IM, Coulibaly D, Kassim S et al. Autopsy-proven causes of death in HIV-infected patients treated for tuberculosis in Abidjan, Cote d'Ivoire. AIDS 1995;9(11):1251-4.
11. Albert JP, Retif M. [Epidemiology of human tuberculosis in West Africa. Results of five surveys carried out by means of tuberculin tests and random sample in different climatic zones of Upper Volta and the Ivory Coast]. Ann.Soc.Belg.Med.Trop. 1972;52(2):75-101.

1. English M, Esamai F, Wasunna A, Were F, Ogutu B, Wamae A et al. Assessment of inpatient paediatric care in first referral level hospitals in 13 districts in Kenya. Lancet 2004;363(9425):1948-53.
2. Githui WA, Jordaan AM, Juma ES, Kinyanjui P, Karimi FG, Kimwomi J et al. Identification of MDR-TB Beijing/W and other Mycobacterium tuberculosis genotypes in Nairobi, Kenya. Int.J.Tuberc.Lung Dis. 2004;8(3):352-60.
3. Laine C, Mwangi T, Thompson CM, Obiero J, Lipsitch M, Scott JA. Age-specific immunoglobulin g (IgG) and IgA to pneumococcal protein antigens in a population in coastal kenya. Infect.Immun. 2004;72(6):3331-5.
4. Siringi S. Kenya proposes tobacco-compensation law. Lancet 2004;363(9425):1963.
5. Chakaya JM, Bii C, Ng'ang'a L, Amukoye E, Ouko T, Muita L et al. Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya. East Afr.Med.J. 2003;80(1):30-5.
6. Currie CS, Williams BG, Cheng RC, Dye C. Tuberculosis epidemics driven by HIV: is prevention better than cure? AIDS 2003;17(17):2501-8.
7. Grant E, Murray SA, Grant A, Brown J. A good death in rural Kenya? Listening to Meru patients and their families talk about care needs at the end of life. J.Palliat.Care 2003;19(3):159-67.
8. Kivihya-Ndugga LE, van Cleeff MR, Githui WA, Nganga LW, Kibuga DK, Odhiambo JA et al. A comprehensive comparison of Ziehl-Neelsen and fluorescence microscopy for the diagnosis of tuberculosis in a resource-poor urban setting. Int.J.Tuberc.Lung Dis. 2003;7(12):1163-71.
9. French N, Williams G, Williamson V, Bhatt SM, Gilks CF. The radiographic appearance of pneumococcal pneumonia in adults is unaltered by HIV-1-infection in hospitalized Kenyans. AIDS 2002;16(15):2095-6.
10. Scott JA, Obiero J, Hall AJ, Marsh K. Validation of immunoglobulin G enzyme-linked immunosorbent assay for antibodies to pneumococcal surface adhesin A in the diagnosis of pneumococcal pneumonia among adults in Kenya. J.Infect.Dis. 2002;186(2):220-6.
11. Wafula EM, Kinyanjui MM, Nyabola L, Tenambergen ED. Effect of improved stoves on prevalence of acute respiration infection and conjunctivitis among children and women in a rural community in Kenya. East Afr.Med.J. 2000;77(1):37-41.
12. Scott JA, Hall AJ, Muyodi C, Lowe B, Ross M, Chohan B et al. Aetiology, outcome, and risk factors for mortality among adults with acute pneumonia in Kenya. Lancet 2000;355(9211):1225-30.
13. HAYNES WS. Tuberculosis in Kenya. Br.Med.J. 1951;4697:67-71.

1. Redd SC, Patrick E, Vreuls R, Metsing M, Moteetee M. Comparison of the clinical and radiographic diagnosis of paediatric pneumonia. Trans.R.Soc.Trop.Med.Hyg. 1994;88(3):307-10.
2. Redd SC, Vreuls R, Metsing M, Mohobane PH, Patrick E, Moteetee M. Clinical signs of pneumonia in children attending a hospital outpatient department in Lesotho. Bull.World Health Organ 1994;72(1):113-8.
3. Kinoti SN. Asphyxia of the newborn in east, central and southern Africa. East Afr.Med.J. 1993;70(7):422-33.
4. Moteetee M, Redd SC, Metsing M. The development of the National ARI Control Programme in Lesotho. Bull.Int.Union Tuberc.Lung Dis. 1990;65(4):29-30.
5. Tracey D, Ramatlapeng T. The Lesotho National Tuberculosis Control Programme. Bull.Int.Union Tuberc.Lung Dis. 1989;64(3):29-31.
6. McGlashan ND, Harington JS, Bradshaw E. Eleven sites of cancer in black gold miners from Southern Africa: a geographic enquiry. Br.J.Cancer 1982;46(6):947-54.
7. Styblo K. Surveillance of tuberculosis. Int.J.Epidemiol. 1976;5(1):63-8.
8. Sutherland I, Fayers PM. The association of the risk of tuberculous infection with age. Bull.Int.Union Tuberc. 1975;50(1):70-81.

1. Sagher F, Hweta A. Bronchoconstrictor effect of exercise in healthy Libyan children in Tripoli. East Mediterr.Health J. 1999;5(2):350-3.
2. Shambesh MK, Craig PS, Gusbi AM, Echtuish EF, Wen H. Immunoblot evaluation of the 100 and 130 kDa antigens in camel hydatid cyst fluid for the serodiagnosis of human cystic echinococcosis in Libya. Trans.R.Soc.Trop.Med.Hyg. 1995;89(3):276-9.
3. Shamssain MH, Thompson J. A comparative study of pulmonary function and body composition in Scottish and Libyan schoolchildren aged 12-17 years. J.Trop.Pediatr. 1992;38(3):121-3.
4. Mukhtar MS, Rao GM, Gamra NS, Afan AM, Zendah MI. Respiratory effects of occupational exposure to tobacco dust. Respiration 1991;58(5-6):271-6.
5. Mukhtar MS, Rao GM, Morghom LO, Patrick JM. Spirometric standards of Libyan boys and girls. Respiration 1989;56(3-4):227-34.
6. Agarwal RK, Banerjee G, Shembish N, Jamal BA, Kareemullah C, Swaleh A. Foreign bodies in the tracheobronchial tree: a review of 102 cases in Benghazi, Libya. Ann.Trop.Paediatr. 1988;8(4):213-6.
7. Shamssain MH. Forced expiratory indices in normal Libyan men. Thorax 1988;43(11):923-5.
8. Taha A, Ball K. Smoking in Africa: the coming epidemic. World Smoking.Health 1982;7(2):25-30.
9. Chuang CY. A clinical investigation of asthmatics in the Misurata area, Libya, North Africa. Taiwan.Yi.Xue.Hui.Za Zhi. 1967;66(5):256-71.
10. Fossati CJ. [Clinico-statistical considerations on the incidence of thoracic hydatidosis and results obtained with medical and surgical treatment in Arabico-libyan patients from Cirenaica (Libya) during the years of 1959-1966 inclusive]. Rev.Clin.Esp. 1967;107(2):108-10.
11. Fossati C. [INCIDENCE OF PULMONARY TUBERCULOSIS AND OTHER DISEASES OF THE RESPIRATORY SYSTEM IN THE ARAB POPULATION OF CYRENAICA DURING THE 2-YEAR PERIOD FROM JULY 1959 TO JULY 1961]. Lotta.Tuberc. 1963;33:416-37.

1. PD C, Bagley SW. Health-related challenges in United States Peace Corps Volunteers serving for two years in Madagascar. J.Travel.Med. 2003;10(5):263-7.
2. Influenza outbreak--Madagascar, July-August 2002. MMWR Morb.Mortal.Wkly.Rep. 2002;51(45):1016-8.
3. Ramarokoto H, Randriamiharisoa H, Rakotoarisaonina A, Rasolovavalona T, Rasolofo V, Chanteau S et al. Bacteriological follow-up of tuberculosis treatment: a comparative study of smear microscopy and culture results at the second month of treatment. Int.J.Tuberc.Lung Dis. 2002;6(10):909-12.
4. Rasolofo R, V, Ramarokoto H, Clouzeau J, Rasolonavalona T, Vololonirina EJ, Cauchoix B et al. [Tuberculosis in children less than 11 years old: primary resistance and dominant genetic variants of Mycobacterium tuberculosis in Antananarivo]. Arch.Inst.Pasteur Madagascar 2002;68(1-2):41-3.
5. Rasolofo-Razanamparany V, Ramarokoto H, Auregan G, Gicquel B, Chanteau S. A combination of two genetic markers is sufficient for restriction fragment length polymorphism typing of Mycobacterium tuberculosis complex in areas with a high incidence of tuberculosis. J.Clin.Microbiol. 2001;39(4):1530-5.
6. Comolet TM, Rakotomalala R, Tsimaniry CA. [Do health workers practice what they preach? A study of knowledge, opinions and practices of health care professionals, with respect to their own health, in Madagascar]. Sante 2000;10(1):5-10.
7. Ratsitorahina M, Chanteau S, Rahalison L, Ratsifasoamanana L, Boisier P. Epidemiological and diagnostic aspects of the outbreak of pneumonic plague in Madagascar. Lancet 2000;355(9198):111-3.
8. Rasoamanana B, Leroy F, Boisier P, Rasolomaharo M, Buchy P, Carniel E et al. Field evaluation of an immunoglobulin G anti-F1 enzyme-linked immunosorbent assay for serodiagnosis of human plague in Madagascar. Clin.Diagn.Lab Immunol. 1997;4(5):587-91.
9. Human plague in 1992. Wkly.Epidemiol.Rec. 1994;69(2):8-10.

1. Cooke GS, Lalvani A, Gleeson FV, Conlon CP. Acute pulmonary schistosomiasis in travellers eturning from Lake Malawi, sub-Saharan Africa. Clin.Infect.Dis 1999;29(4):836-9.
2. Cruz JR, Heldal E, Arnadottir T, Juarez I, Enarson DA. Tuberculosis case-finding in Nicaragua: evaluation of routine activities in the control programme. Tuber.Lung Dis 1994;75(6):417-22.
3. Gordon SB, Molyneux ME, Boeree MJ, Kanyanda S, Chaponda M, Squire SB, Read RC. Opsonic phagocytosis of Streptococcus pneumoniae by alveolar macrophages is not impaired in human immunodeficiency virus-infected Malawian adults. J Infect.Dis 2001;184(10):1345-9.
4. Gordon SB, Miller DE, Day RB, Ferry T, Wilkes DS, Schnizlein-Bick CT, Zijlstra EE, Read RC, Molyneux ME, Twigg HL, III. Pulmonary immunoglobulin responses to Streptococcus pneumoniae are altered but not reduced in human immunodeficiency virus-infected Malawian adults. J Infect.Dis 2003;188(5):666-70.
5. Graham SM, Daley HM, Ngwira B. Finger clubbing and HIV infection in Malawian children. Lancet 1997;349(9044):31.
6. Harries AD, Nyangulu DS, Banda H, Kang'ombe C, Van der PL, Glynn JR, Subramanyam VR, Wirima JJ, Salaniponi FM, Maher D, Nunn P. Efficacy of an unsupervised ambulatory treatment regimen for smear-negative pulmonary tuberculosis and tuberculous pleural effusion in Malawi. Int J Tuberc Lung Dis 1999;3(5):402-8.
7. Salanitri J, Stanley P, Hennessy O. Acute pulmonary schistosomiasis. Australas.Radiol. 2002;46(4):435-7.

1. Kayantao D, Maiga I, Bougoudogo F, Pouabe TR, Keita B, Sangare S. [Radiographic and bacteriologic data on pulmonary tuberculosis in Bamako as a function of HIV status]. Rev.Pneumol.Clin. 2001;57(6):423-6.
2. Kayantao D, Toloba Y, Kamissoko M, Keita B, Diallo S, M'Baye O et al. [Epidemiological, clinical and progressive aspects of asthma observed at Bamako, Mali]. Sante 2001;11(2):101-3.
3. Ait-Khaled N, Auregan G, Bencharif N, Camara LM, Dagli E, Djankine K et al. Affordability of inhaled corticosteroids as a potential barrier to treatment of asthma in some developing countries. Int.J.Tuberc.Lung Dis. 2000;4(3):268-71.
4. Kayantao D, Keita B, Sangare S. [The results of retreatment of pulmonary tuberculosis using a short 6-month protocol 1985-1991 in the pneumo-phthisiology department of the Point G hospital in Bamako]. Bull.Soc.Pathol.Exot. 1997;90(2):124-7.
5. Kodio B, Traore B, Cordetta P, Traore AK, Marjolet M, Ag RA et al. [Prevalence of pulmonary tuberculosis and HIV infection in the district of Dire in Mali]. Bull.Soc.Pathol.Exot. 1995;88(4):174-8.
6. Keita B, Samake L, Sangare S. [Factors in quitting antituberculous treatment in Bamako (Mali)]. Rev.Mal Respir. 1994;11(6):579-82.
7. Mohamed AA. [Laryngo-tracheobronchial foreign bodies. Apropos of 20 cases]. Bull.Soc.Pathol.Exot. 1993;86(5):369-71.
8. Bayo S, Parkin DM, Koumare AK, Diallo AN, Ba T, Soumare S et al. Cancer in Mali, 1987-1988. Int.J.Cancer 1990;45(4):679-84.
9. Duflo B, Balique H, Ranque P, Diallo AN, Brucker G, Alavi H et al. [Estimation of the impact of the principal diseases in rural Mali]. Rev.Epidemiol.Sante Publique 1986;34(6):405-18.
10. Ehrengut W, Sarateanu DE, AgRhaly A, Koumare B, Simaga SY, Diallo D. Prevalence of antibodies against respiratory viruses in children of Koulikoro (Mali). Tropenmed.Parasitol. 1984;35(2):119-22.

1. Bardonnet K, Piarroux R, Dia L, Schneegans F, Beurdeley A, Godot V et al. Combined eco-epidemiological and molecular biology approaches to assess Echinococcus granulosus transmission to humans in Mauritania: occurrence of the 'camel' strain and human cystic hinococcosis Trans.R.Soc.Trop.Med.Hyg. 2002;96(4):383-6.
2. Expanded programme on immunization. Immunization in the Maghreb. Wkly.Epidemiol.Rec. 1990;65(15):109-12.
3. Amblard J. [Tuberculosis control in the regional health district of Mauritanian Adrar (September 1976 to September 1980)]. Med.Trop.(Mars.) 1984;44(1):49-56.

1. Benslama A, Moutaouakkil S, Charra B, Menebhi L. [The intermediate syndrome during organophosphorus pesticide poisoning]. Ann.Fr.Anesth.Reanim. 2004;23(4):353-6.
2. Brugge WR, Mueller PR, Misdraji J. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 8-2004. A 28-year-old man with abdominal pain, fever, and a mass in the region of the pancreas. N.Engl.J.Med. 2004;350(11):1131-8.
3. Dent J, Armstrong D, Delaney B, Moayyedi P, Talley NJ, Vakil N. Symptom evaluation in reflux disease: workshop background, processes, terminology, recommendations, and discussion outputs. Gut 2004;53 Suppl 4:iv1-24.
4. Kanouni L, Jalil A, Saadi I, Sifat H, Hadadi K, Errihani H et al. [Management of phyllodes tumors of the breast at the National institute of oncology of Rabat, Morocco]. Gynecol.Obstet.Fertil. 2004;32(4):293-301.
5. Koukal B, Dominik J, Vignati D, Arpagaus P, Santiago S, Ouddane B et al. Assessment of water quality and toxicity of polluted Rivers Fez and Sebou in the region of Fez (Morocco). Environ.Pollut. 2004;131(1):163-72.
6. Macpherson CN, Kachani M, Lyagoubi M, Berrada M, Shepherd M, Fields PF et al. Cystic echinococcosis in the Berber of the Mid Atlas mountains, Morocco: new insights into the natural history of the disease in humans. Ann.Trop.Med.Parasitol. 2004;98(5):481-90.
7. McCarthy P, Chammas G, Wilimas J, Alaoui FM, Harif M. Managing children's cancer pain in Morocco. J.Nurs.Scholarsh. 2004;36(1):11-5.
8. Moussaid L, Benchikhi H, Boukind EH, Sqalli S, Mouaki N, Kadiri F et al. [Cutaneous tumors during xeroderma pigmentosum in Morocco: study of 120 patients]. Ann.Dermatol.Venereol. 2004;131(1 Pt 1):29-33.
9. Remus N, El Baghdadi J, Fieschi C, Feinberg J, Quintin T, Chentoufi M et al. Association of IL12RB1 Polymorphisms with Pulmonary Tuberculosis in Adults in Morocco. J.Infect.Dis. 2004;190(3):580-7.
10. Russo EB, Merzouki A, Mesa JM, Frey KA, Bach PJ. Cannabis improves night vision: a case study of dark adaptometry and scotopic sensitivity in kif smokers of the Rif mountains of northern Morocco. J.Ethnopharmacol. 2004;93(1):99-104.

1. Blaylock R. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa. Toxicon 2004;43(2):159-66.
2. Cliff J, Walt G, Nhatave I. What's in a name? Policy transfer in Mozambique: DOTS for tuberculosis and syndromic management for sexually transmitted infections. J.Public Health Policy 2004;25(1):38-55.
3. Gonzalez-Block MA. What's in a policy context?. J.Public Health Policy 2004;25(1):56-7.
4. Mavale-Manuel S, Alexandre F, Duarte N, Albuquerque O, Scheinmann P, Poisson-Salomon AS et al. Risk factors for asthma among children in Maputo (Mozambique). Allergy 2004;59(4):388-93.
5. Rostad B, Schei B, da Costa F, Onsrud M. [Risk factors of cervical cancer among women in Mozambique]. Tidsskr.Nor Laegeforen. 2004;124(10):1410-2.
6. Baumeister EG, Hunicken DS, Savy VL. RSV molecular characterization and specific antibody response in young children with acute lower respiratory infection. J.Clin.Virol. 2003;27(1):44-51.
7. Carrilho C, Gouveia P, Cantel M, Alberto M, Buane L, David L. Characterization of human papillomavirus infection, P53 and Ki-67 expression in cervix cancer of Mozambican women Pathol.Res.Pract. 2003;199(5):303-11.
8. Ito A, Yamasaki H, Nakao M, Sako Y, Okamoto M, Sato MO et al. Multiple genotypes of Taenia solium--ramifications for diagnosis, treatment and control. Acta Trop. 2003;87(1):95-101.
9. McGlashan ND, Harington JS, Chelkowska E. Changes in the geographical and temporal patterns of cancer incidence among black gold miners working in South Africa, 1964-1996. Br.J.Cancer 2003;88(9):1361-9.
10. Ohta N, Aizu M, Kaneko T, Sato T, Kobayashi H. Damage to the gills, skin and other tissues by lysenin and the coelomic fluid of the earthworm Eisenia foetida in two teleosts, Tanichthys albonubes and Oreochromis mossambicus. J.Exp.Zoolog.Part A Comp Exp.Biol. 2003;295(2):117-26.

1. Walker AR, Adam F, Walker BF. World pandemic of obesity: the situation in Southern African populations. Public Health 2001;115(6):368-72.
2. Haas WH, Engelmann G, Amthor B, Shyamba S, Mugala F, Felten M et al. Transmission dynamics of tuberculosis in a high-incidence country: prospective analysis by PCR DNA fingerprinting. J.Clin.Microbiol. 1999;37(12):3975-9.
3. Wessels G, Hesseling PB. Incidence and frequency rates of childhood cancer in Namibia S.Afr.Med.J. 1997;87(7):885-9.
4. O'Keefe SJ, Lavender R. The plight of modern Bushmen. Lancet 1989;2(8657):255-8.
5. De Kock MA, Swiegers WR, Kotze TJ, Joubert G. Cross-sectional study of uranium mine workers to develop predictive equations for lung functions with reference to chronic obstructive pulmonary disease. S.Afr.Med.J. 1988;Suppl:1-20.
6. Sluis-Cremer GK. Change in the prevalence of active pulmonary tuberculosis discovered at autopsy in black miners. S.Afr.Med.J. 1980;58(2):58-61.

1. Simoes EA, Peterson S, Gamatie Y, Kisanga FS, Mukasa G, Nsungwa-Sabiiti J et al. Management of severely ill children at first-level health facilities in sub-Saharan Africa when referral s difficult. Bull.World Health Organ 2003;81(7):522-31.
2. Affinnih YH. Revisiting sub-Saharan African countries' drug problems: health, social, economic costs, and drug control policy. Subst.Use.Misuse. 2002;37(3):265-90.
3. Cenac A, Djibo A, Chaigneau C, Degbey H, Sueur JM, Orfila J. [Chlamydia pneumoniae and acute respiratory tract infections in breast-feeding infants: simultaneous mother-child serological study in Niamey (Niger)]. Sante 2002;12(2):217-21.
4. Chippaux JP, Houssier S, Gross P, Bouvier C, Brissaud F. [Pollution of the groundwater in the city of Niamey, Niger]. Bull.Soc.Pathol.Exot. 2002;95(2):119-23.
5. Edson WN, Koniz-Booher P, Boucar M, Djbrina S, Mahamane I. The role of research in developing job aids for pneumonia treatment in Niger. Int.J.Qual.Health Care 2002;14 Suppl 1:35-45.
6. Liam CK, Loo KL, Wong CM, Lim KH, Lee TC. Skin prick test reactivity to common aeroallergens in asthmatic patients with and without rhinitis. Respirology. 2002;7(4):345-50.
7. MURAZ. [The organization of a Committee for Aid to tuberculous Students Overseas; the F.S.N.N., Formation Sanitaire Nomade motorisee du Niger francais (A.O.F.).]. Bull.Acad.Natl.Med. 1953;137(34-5):580-4.

1. Amusa YB, Akinpelu VO, Fadiora SO, Agbakwuru EA. Tracheostomy in surgical practice: xperience in a Nigerian tertiary hospital. West Afr.J.Med. 2004;23(1):32-4.
2. Brumfiel G. US biologist accused of robbing colleagues. Nature 2004;428(6983):591.
3. Falade AG, Olawuyi JF, Osinusi K, Onadeko BO. Prevalence and severity of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema in 6- to 7-year-old Nigerian primary school children: the international study of asthma and allergies in childhood. Med.Princ.Pract. 2004;13(1):20-5.
4. Glew RH, Brock HS, VanderVoort J, Agaba P, Harkins MS, VanderJagt DJ. Lung function and nutritional status of semi-nomadic Fulani children and adolescents in northern Nigeria. J.Trop.Pediatr. 2004;50(1):20-5.
5. Ijadunola KT, Erhabor GE, Onayade AA, Ijadunola MY, Fatusi AO, Asuzu MC. Prevalence of respiratory symptoms among wheat flour mill workers in Ibadan, Nigeria. Am.J.Ind.Med. 2004;45(3):251-9.
6. Malami SA, Mungadi IA, Pindiga UH, Abimiku BA. Cancer registration in a developing country: problems and prospects of the new UDUTH Cancer Registry, Sokoto, Nigeria. Trop.Doct. 2004;34(2):126-7.
7. Adegboye VO, Osinowo O, Adebo OA. Bronchiectasis consequent upon prolonged foreign body retention. Cent.Afr.J.Med. 2003;49(5-6):53-8.
8. Enwuru CA, Idigbe EO, Ezeobi NV, Otegbeye AF. Care-seeking behavioural patterns, awareness and diagnostic processes in patients with smear- and culture-positive pulmonary tuberculosis in Lagos, Nigeria. Trans.R.Soc.Trop.Med.Hyg. 2002;96(6):614-6.
9. Hargreaves S. Time to right the wrongs: improving basic health care in Nigeria. Lancet 2002;359(9322):2030-5. 10. BRAUN EH. Tuberculosis in Nigeria. Tubercle. 1953;34(11):301-7.

1. Rutta E, Kipingili R, Lukonge H, Assefa S, Mitsilale E, Rwechungura S. Treatment outcome among Rwandan and Burundian refugees with sputum smear-positive tuberculosis in Ngara, Tanzania. Int.J.Tuberc.Lung Dis. 2001;5(7):628-32.
2. War, oppression, refugee camps fuel spread of HIV. Migration and HIV. Bridg.Wash.D.C. 1998(5):4-5.
3. Di Perri G, Cazzadori A, Vento S, Allegranzi B, Nardi S, Brunello F et al. Tuberculosis among refugees and displaced people at the Burundi-Rwanda border. Clin.Infect.Dis.1998;26(2):500-1.
4. Rwangabwoba JM, Fischman H, Semba RD. Serum vitamin A levels during tuberculosis and human immunodeficiency virus infection. Int.J.Tuberc.Lung Dis. 1998;2(9):771-3.
5. Anglaret X, Taelman H, Ladner J, Batungwanayo J, Dabis F. Tuberculosis and chemoprophylaxis in Africa. Lancet 1995;345(8953):867-8.
6. Prakash UB. Respiratory diseases in Rwanda. Chest 1995;108(1):5-7.
7. Batungwanayo J, Taelman H, Lucas S, Bogaerts J, Alard D, Kagame A et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda. A fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am.J.Respir.Crit Care Med. 1994;149(6):1591-6.
8. Batungwanayo J, Taelman H, Bogaerts J, Allen S, Lucas S, Kagame A et al. Pulmonary cryptococcosis associated with HIV-1 infection in Rwanda: a retrospective study of 37 cases. AIDS 1994;8(9):1271-6.
9. Batungwanayo J, Taelman H, Allen S, Bogaerts J, Kagame A, Van de PP. Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda. AIDS 1993;7(1):73-9.
10. Jadin JB, Vanderick F, Mbonyingabo. First case of Histoplasma duboisi in Rwanda. Trans.R.Soc.Trop.Med.Hyg. 1972;66(1):14.

1. Affinnih YH. Revisiting sub-Saharan African countries' drug problems: health, social, economic costs, and drug control policy. Subst.Use.Misuse. 2002;37(3):265-90.
2. Pampiglione S, Visconti S, Pezzino G. [Human intestinal parasites in Subsaharan Africa. II. Sao Tome and Principe]. Parassitologia 1987;29(1):15-25.

1. Mark DT. New vaccines against tuberculosis. Trop.Med.Int.Health 2004;9(7):818-26.
2. Diouf S, Sy HS, Camara B, Sarr M, Kuakuvi N. [Current aspects of tuberculosis in Dakar pediatric area]. Arch.Pediatr. 2003;10(12):1098-9.
3. Echave P, Bille J, Audet C, Talla I, Vaudaux B, Gehri M. Percentage, bacterial etiology and antibiotic susceptibility of acute respiratory infection and pneumonia among children in rural Senegal. J.Trop.Pediatr. 2003;49(1):28-32.
4. Ndiaye M, Ndir M, Quantin X, Demoly P, Godard P, Bousquet J. [Smoking habits, attitudes and knowledges of medical students of Medicine, Pharmacy and Odonto-Stomatology's Faculty of Dakar, Senegal]. Rev.Mal Respir. 2003;20(5 Pt 1):701-9.
5. Diop AH, Gakiria G, Pande SB, Malla P, Rieder HL. Dosages of anti-tuberculosis medications in the national tuberculosis programs of Kenya, Nepal, and Senegal. Int.J.Tuberc.Lung Dis. 2002;6(3):215-21.
6. Gehri M, Gautier E, Sall S, Mbaye A, Cotting J. [Grunting in Senegalese children: a symptom predictive of death or serious illness]. Arch.Pediatr. 2001;8(6):667-8.
7. Maynart M, Lievre L, Sow PS, Kony S, Gueye NF, Bassene E et al. Primary prevention with cotrimoxazole for HIV-1-infected adults: results of the pilot study in Dakar, Senegal. J.Acquir.Immune.Defic.Syndr. 2001;26(2):130-6.
8. Dosseh A, Ndiaye K, Spiegel A, Sagna M, Mathiot C. Epidemiological and virological influenza survey in Dakar, Senegal: 1996-1998. Am.J.Trop.Med.Hyg. 2000;62(5):639-43.
9. Macondo EA, Ba F, Toure-Kane NC, Kaire O, Gueye-Ndiaye A, Gaye-Diallo A et al. [Improvement of tuberculosis diagnosis by the Mycobacteria Growth Indicator Tube (MGIT) in a developing country laboratory]. Bull.Soc.Pathol.Exot. 2000;93(2):97-100.
10. Sarrat H, Castets M. [Mycobacteria isolated from humans in Dakar in 1966]. Bull.Soc.Med.Afr.Noire.Lang Fr. 1967;12(3):402-6.

1. Yersin C, Bovet P, Merien F, Clement J, Laille M, Van Ranst M et al. Pulmonary haemorrhage as a predominant cause of death in leptospirosis in Seychelles. Trans.R.Soc.Trop.Med.Hyg. 2000;94(1):71-6.
2. Yersin C, Bovet P, Merien F, Wong T, Panowsky J, Perolat P. Human leptospirosis in the Seychelles (Indian Ocean): a population-based study. Am.J.Trop.Med.Hyg. 1998;59(6):933-40.
3. Sullivan FM, Shamlaye C. Primary medical care in Seychelles. Trop.Doct. 1992;22(3):100-4.
4. Chennabathni CS, Brown DJ. Prescribing patterns in Seychelles. Trop.Doct. 1982;12(4 Pt 2):228-30.
5. Grainger CR. Deaths in Seychelles due to neoplasms, 1959-78. Trop.Doct. 1981;11(3):106-9.

1. Brice SE, Oldfield MD, Barker R. Stridor, malaise, and visual loss in a woman from Sierra Leone. Postgrad.Med.J. 2001;77(911):601, 607-1, 608.
2. Frothingham R, Strickland PL, Bretzel G, Ramaswamy S, Musser JM, Williams DL. Phenotypic and genotypic characterization of Mycobacterium africanum isolates from West Africa. J.Clin.Microbiol. 1999;37(6):1921-6.
3. Gibson N, Boillot F, Jalloh H. The cost of tuberculosis to patients in Sierra Leone's war zone. Int.J.Tuberc.Lung Dis. 1998;2(9):726-31.
4. Hodges M, Williams RA. Registered infant and under-five deaths in Freetown, Sierra Leone from 1987-1991 and a comparison with 1969-1979. West Afr.J.Med. 1998;17(2):95-8.
5. Boillot F, Peeters M, Kosia A, Delaporte E. Prevalence of the human immunodeficiency virus among patients with tuberculosis in Sierra Leone, established from dried blood spots on filter paper. Int.J.Tuberc.Lung Dis. 1997;1(6):493-7.
6. Odonkor PO, Morgan MW, Palmer LT, Sankoh EU. Spirometric measurements in healthy Sierra Leoneans. West Afr.J.Med. 1997;16(2):112-6.
7. Abul BS, Lisk RD. Tobacco and cannabis smoking in secondary school pupils in Bo, Sierra Leone. West Afr.J.Med. 1995;14(3):157-60.
8. Gibson J. Drug-resistant tuberculosis in Sierra Leone. Tubercle. 1986;67(2):119-24.
9. Wilkinson JL. Children in hospital in Sierra Leone: a survey of 10,000 admissions. Trans.R.Soc.Trop.Med.Hyg. 1969;63(2):263-9.
10. TUBOKU-METZGER AF. Pulmonary tuberculosis in Sierra Leone. Tubercle. 1962;43:454-5.

1. Shetty N, Shemko M, Abbas A. Knowledge, attitudes and practices regarding tuberculosis among immigrants of Somalian ethnic origin in London: a cross-sectional study. Commun.Dis.Public Health 2004;7(1):77-82.
2. Kempainen R, Nelson K, Williams DN, Hedemark L. Mycobacterium tuberculosis disease in Somali immigrants in Minnesota. Chest 2001;119(1):176-80.
3. Lillebaek T, Andersen AB, Bauer J, Dirksen A, Glismann S, de Haas P et al. Risk of Mycobacterium tuberculosis transmission in a low-incidence country due to immigration from high-incidence areas. J.Clin.Microbiol. 2001;39(3):855-61.
4. Bekele T. Studies on the respiratory disease 'sonbobe' in camels in the eastern lowlands of Ethiopia. Trop.Anim Health Prod. 1999;31(6):333-45.
5. Mohamed J. Epidemics and public health in early colonial Somaliland. Soc.Sci.Med. 1999;48(4):507-21.
6. Sheik-Mohamed A, Velema JP. Where health care has no access: the nomadic populations of sub-Saharan Africa. Trop.Med.Int.Health 1999;4(10):695-707.
7. Grabenstein JD, Filby CL, Vauter RA, Harris TR, Wilson JP. Prescribed medication use among troops deploying to Somalia: pharmacoepidemiologic analysis. Mil.Med. 1995;160(11):571-7.
8. Toole MJ. Mass population displacement. A global public health challenge. Infect.Dis.Clin.North Am. 1995;9(2):353-66.
9. Murray MJ, Murray AB, Murray MB, Murray CJ. The adverse effect of iron repletion on the course of certain infections. Br.Med.J. 1978;2(6145):1113-5.
10. Abbas AS. Common diseases of the pre-school child in Mogadishu General Hospital. East Afr.Med.J. 1975;52(3):157-61.

Full listing

1. Abdool-Karim SS, Abdool-Karim Q, Friedland G, Lalloo U, El Sadr WM. Implementing antiretroviral therapy in resource-constrained settings: opportunities and challenges in integrating HIV and tuberculosis care. AIDS 2004;18(7):975-9.
2. Abratt RP, Vorobiof DA, White N. Asbestos and mesothelioma in South Africa. Lung Cancer 2004;45 Suppl 1:S3-S6.
3. Ayo-Yusuf OA, Swart TJ, Pickworth WB. Nicotine delivery capabilities of smokeless tobacco products and implications for control of tobacco dependence in South Africa. Tob.Control 2004;13(2):186-9.
4. Barnes BR, Mathee A, Shafritz LB, Krieger L, Zimicki S. A behavioral intervention to reduce child exposure to indoor air pollution: identifying possible target behaviors. Health Educ.Behav. 2004;31(3):306-17.
5. Bateman ED, Boushey HA, Bousquet J, Busse WW, Clark TJ, Pauwels RA et al. Can Guideline-defined Asthma Control be Achieved? The Gaining Optimal Asthma ControL Study. Am.J.Respir.Crit Care Med. 2004.
6. Besselaar TG, Botha L, McAnerney JM, Schoub BD. Antigenic and molecular analysis of influenza A (H3N2) virus strains isolated from a localised influenza outbreak in South Africa in 2003. J.Med.Virol. 2004;73(1):71-8.
7. Blaylock R. Epidemiology of snakebite in Eshowe, KwaZulu-Natal, South Africa. Toxicon 2004;43(2):159-66.
8. Charalambous S, Grant AD, Day JH, Rothwell E, Chaisson RE, Hayes RJ et al. Feasibility and acceptability of a specialist clinical service for HIV-infected mineworkers in South Africa. AIDS Care 2004;16(1):47-56.
9. Jack C, Lalloo U, Karim QA, Karim SA, El Sadr W, Cassol S et al. A Pilot Study of Once-Daily Antiretroviral Therapy Integrated With Tuberculosis Directly Observed Therapy in a Resource-Limited Setting. J.Acquir.Immune.Defic.Syndr. 2004;36(4):929-34.
10. Madhi SA, Klugman KP, The Vaccine Trialist Group. A role for Streptococcus pnemoniae in virus-associated pneumonia. Nat.Med. 2004.

1. Ahmed HG, Idris AM, Ibrahim SO. Study of oral epithelial atypia among Sudanese tobacco users by exfoliative cytology. Anticancer Res. 2003;23(2C):1943-9.
2. Doczeova A, Liskova A, Krcmery V, Jr. Low antibiotic resistance in respiratory pathogens in a remote area in southern Sudan that was isolated by civil war for 18 years. Clin.Infect.Dis. 2003;37(11):1582.
3. El Sony AI, Mustafa SA, Khamis AH, Sobhi S, Enarson DA, Baraka OZ et al. Symptoms in patients attending services for diagnosis of pulmonary tuberculosis in Sudan. Int.J.Tuberc.Lung Dis. 2003;7(6):550-5.
4. El Sony AI, Mustafa SA, Khamis AH, Enarson DA, Baraka OZ, Bjune G. The effect of decentralisation on tuberculosis services in three states of Sudan. Int.J.Tuberc.Lung Dis. 2003;7(5):445-50.
5. Hehenkamp A, Hargreaves S. Tuberculosis treatment in complex emergencies: South Sudan. Lancet 2003;362 Suppl:s30-s31.
6. El Sony A, Enarson D, Khamis A, Baraka O, Bjune G. Relation of grading of sputum smears with clinical features of tuberculosis patients in routine practice in Sudan. Int.J.Tuberc.Lung Dis. 2002;6(2):91-7.
7. El Sony AI, Khamis AH, Enarson DA, Baraka O, Mustafa SA, Bjune G. Treatment results of DOTS in 1797 Sudanese tuberculosis patients with or without HIV co-infection. Int.J.Tuberc.Lung Dis. 2002;6(12):1058-66.
8. Hamid ME, Maldonado L, Sharaf Eldin GS, Mohamed MF, Saeed NS, Goodfellow M. Nocardia africana sp. nov., a new pathogen isolated from patients with pulmonary infections. J.Clin.Microbiol. 2001;39(2):625-30.
9. Marshall BG, Kropf P, Murray K, Clark C, Flanagan AM, Davidson RN et al. Bronchopulmonary and mediastinal leishmaniasis: an unusual clinical presentation of Leishmania donovani infection. Clin.Infect.Dis. 2000;30(5):764-9.
10. SANKALE M, PLESSIS J, DUCLOUX M, GENTILLINI M. [Tuberculous endemicity in the Gao region (Sudan Republic)]. Bull.Soc.Pathol.Exot.Filiales. 1959;52:587-91.

1. Wright J, Walley J, Philip A, Pushpananthan S, Dlamini E, Newell J et al. Direct observation of treatment for tuberculosis: a randomized controlled trial of community health workers versus family members. Trop.Med.Int.Health 2004;9(5):559-65.
2. McCulloch J. Asbestos mining in Southern Africa, 1893-2002. Int.J.Occup.Environ.Health 2003;9(3):230-5.
3. Pritchard D, Sitas F, Viljoen E. Tobacco consumption among Swaziland high-school students and their parents and teachers. S.Afr.Med.J. 1999;89(5):558-9.
4. Assessment of mortality levels, trends and differentials in relation to the goal of "Health for All" by year 2000 in some ECA member states. Afr.Popul.Newsl. 1993(63-64):10-1.
5. Mulholland EK, Simoes EA, Costales MO, McGrath EJ, Manalac EM, Gove S. Standardized diagnosis of pneumonia in developing countries. Pediatr.Infect.Dis.J. 1992;11(2):77-81.
6. Simoes EA, McGrath EJ. Recognition of pneumonia by primary health care workers in Swaziland with a simple clinical algorithm. Lancet 1992;340(8834-8835):1502-3.
7. Peers F, Bosch X, Kaldor J, Linsell A, Pluijmen M. Aflatoxin exposure, hepatitis B virus infection and liver cancer in Swaziland. Int.J.Cancer 1987;39(5):545-53.
8. Shennan DH. Comparison of a conventional and an initial 2-month intensive drug regimen for treating pulmonary tuberculosis in Swaziland. Tubercle. 1984;65(2):101-4.
9. McDermott M, Bevan MM, Elmes PC, Allardice JT, Bradley AC. Lung function and radiographic change in chrysotile workers in Swaziland. Br.J.Ind.Med. 1982;39(4):338-43.

1. Mwaiselage J, Bratveit M, Moen B, Mashalla Y. Cement Dust Exposure and Ventilatory Function Impairment: An Exposure-Response Study. J.Occup.Environ.Med. 2004;46(7):658-67.
2. Rongo LM, Msamanga GI, Burstyn I, Barten F, Dolmans WM, Heederik D. Exposure to wood dust and endotoxin in small-scale wood industries in Tanzania Expo.Anal.Environ.Epidemiol. 2004.
3. Egwaga SM. The impact of HIV on transmission of tuberculosis in Tanzania. Tuberculosis.(Edinb.) 2003;83(1-3):66-7.
4. Mugusi FM, Rusizoka O, Habib N, Fawzi W. Vitamin A status of patients presenting with pulmonary tuberculosis and asymptomatic HIV-infected individuals, Dar es Salaam, Tanzania. Int.J.Tuberc.Lung Dis. 2003;7(8):804-7.
5. Jagoe K, Edwards R, Mugusi F, Whiting D, Unwin N. Tobacco smoking in Tanzania, East Africa: population based smoking prevalence using expired alveolar carbon monoxide as a validation tool. Tob.Control 2002;11(3):210-4.
6. Kahigwa E, Schellenberg D, Schellenberg JA, Aponte JJ, Alonso PL, Menendez C. Inter-observer variation in the assessment of clinical signs in sick Tanzanian children Trans.R.Soc.Trop.Med.Hyg. 2002;96(2):162-6.
7. Brabin BJ, Rizwan S. Prenatal risk factors of wheezing at the age of four years in Tanzania Thorax 2001;56(11):897.
8. Birrell G, Birrell KG. Assessment of a 1-year teaching programme in Zanzibar, Tanzania Lancet 2000;356(9235):1084.
9. Fawzi WW, Mbise R, Spiegelman D, Fataki M, Hertzmark E, Ndossi G. Vitamin A supplements and diarrheal and respiratory tract infections among children in Dar es Salaam, Tanzania. J.Pediatr. 2000;137(5):660-7.
10. Sunyer J, Torregrosa J, Anto JM, Menendez C, Acosta C, Schellenberg D et al. The association between atopy and asthma in a semirural area of Tanzania (East Africa). Allergy 2000;55(8):762-6.
11. Good MJ, Mwaikambo E, Amayo E, Machoki JM. Clinical realities and moral dilemmas: contrasting perspectives from academic medicine in Kenya, Tanzania, and America. Daedalus. 1999;128(4):167-96.
12. JOHNSTONE G. HISTOPLASMOSIS IN TANGANYIKA (TANZANIA). J.Trop.Med.Hyg. 1965;68:85-91.

1. Agbere AR, Agossou AA, Djeumou J, Bakonde B, Atakouma YD, Tatagan-Agbi K et al. [Tuberculosis in children at the Tokoin University Medical Center of Lome, Togo. 202 cases in the pediatric service (1980-1990)]. Tunis Med. 1999;77(3):149-53.
2. Kpemissi E, Agbere A, Kessie K, Gnamey K, Assimadi K. [Laryngeal, tracheal and bronchial foreign bodies in Togo: diagnostic and therapeutic problems]. Med.Trop.(Mars.) 1995;55(4):395-6.
3. Tidjani O, Gbadoe AH, Grunitzky-Bekele M, Adjadja K, Lawson-Apetoh A, Djinadou G. [Pulmonary abscess in Lome. Apropos of 144 cases collected in the Pneumo-Phthisiology Department of the University Hospital Center-Tokoin from 1981-1993]. Bull.Soc.Pathol.Exot. 1995;88(3):95-6.
4. Tidjani O, Grunitzky B, Sadjo H, Guerin N. [The prophylaxis of tuberculosis and vaccination with BCG. A recent study]. Ann.Pediatr.(Paris) 1992;39(2):99-105.
5. Assimadi K, Assogba L, Locoh-Donou T, Ategbo S, Siamevi K, Dormont S. [Routes of care and health of children in Togo]. Bull.Soc.Pathol.Exot. 1991;84(5 Pt 5):794-803.
6. Dufetel P, Sambiani K, Togbey K, Kolani M. [Characteristics of lung volume and expiratory flow seen in black Africans adults]. Rev.Mal Respir. 1990;7(3):215-22.
7. Tidjani O, Amedome A, ten Dam HG. The protective effect of BCG vaccination of the newborn against childhood tuberculosis in an African community. Tubercle. 1986;67(4):269-81.
8. Marjolet M, Vermeil C. Histoplasmosis duboisii. Notes and comments on two African cases observed in Nantes. Mykosen 1984;27(11):547-51.
9. Begue P, Sondo B, Assimadi K. [Bacterial pneumonia and empyema in infants and children. Sixty cases seen in Togo (author's transl)]. Ann.Pediatr.(Paris) 1982;29(3):219-24.
10. Espinasse J, Chantal J, Faye P, Akakpo JA, Le Layec C, L'Haridon R et al. [Main respiratory virus and Chlamydia psittaci antibody survey by passive hemagglutination on bovine serum from Togo]. Rev.Elev.Med.Vet.Pays Trop. 1980;33(1):15-20.
11. Amedome A, Palanga A. [Screening of pulmonary tuberculosis by microscopic examination of sputum and new supervised drug therapy in Togo]. Bull.Int.Union Tuberc. 1973;48 Suppl:105-31.
12. Amedome AA. [Problems with tuberculosis prevention in Togo]. Rev.Tuberc.Pneumol.(Paris) 1967;31(3):384-400.

1. Ben Ali M, Barbouche MR, Bousnina S, Chabbou A, Dellagi K. Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients. Clin.Diagn.Lab Immunol. 2004;11(3):625-6.
2. Fodha I, Vabret A, Trabelsi A, Freymuth F. Epidemiological and antigenic analysis of respiratory syncytial virus in hospitalised Tunisian children, from 2000 to 2002. J.Med.Virol. 2004;72(4):683-7.
3. Ben Mustapha MA, Ben Said M. [Pressurized metered dose inhalers for the Tunisian asthmatic]. Tunis Med. 2003;81(6):407-14.
4. Benzarti M, Mezghanni S, Jerray M, Garrouche A, Hayouni A. [The quality of life in a Tunisian population of asthmatic patients]. Tunis Med. 2003;81(5):308-17.
5. Bouraoui S, Haouet S, Mekni A, el Ouertani L, Bellil K, Bellil S et al. [Extrapulmonary tuberculosis in Tunisia. Report of 830 cases. Experience of the Anatomic Pathology Laboratory of the Rabta Hospital]. Tunis Med. 2003;81(8):529-34.
6. Boussoffara R, Mechri A, Knani J, Slama R, Ben Salem N, Tabka Z et al. [Involved factors in stability of children's asthma. A study of 150 children in Mahdia]. Tunis Med. 2003;81(3):190-4.
7. Cattan D. Familial Mediterranean fever: is low mortality from tuberculosis a specific advantage for MEFV mutations carriers? Mortality from tuberculosis among Muslims, Jewish, French, Italian and Maltese patients in Tunis (Tunisia) in the first half of the 20th century. Clin.Exp.Rheumatol. 2003;21(4 Suppl 30):S53-S54.
8. Fakhfakh R, Aouina H, Gharbi L, Hsairi H, Achour N, Lagrue G et al. [Smoking dependence and symptoms of anxiety and depression among Tunisian smokers]. Rev.Mal Respir. 2003;20(6 Pt 1):850-7.
9. Thabet L, Boutiba I, Kammoun A, Khelif L, Mahjoubi F, Smaoui H et al. [Epidemiologic profile of Haemophilus influenzae infection in Tunisia]. Tunis Med. 2002;80(8):469-72.
10. Soltani MS, Bchir A. [Smoking behavior and attitude to smoking of medical students (Tunisian Sahel)]. Rev.Mal Respir. 2000;17(1):77-82.
11. Chouchane L, Sfar I, Bousaffara R, El Kamel A, Sfar MT, Ismail A. A repeat polymorphism in interleukin-4 gene is highly associated with specific clinical phenotypes of asthma. Int.Arch.Allergy Immunol. 1999;120(1):50-5.
12. Boutiba-Ben Boubaker I, Ben Hassen A, Kammoun A, Ben Redjeb S. [Epidemiology and sensitivity of Streptococcus pneumonia to antibiotics. Data in a Tunisian hospital (1986-1996)]. Tunis Med. 1998;76(11):380-3.
13. GOUJOU J, DIDIER R. [The medical and social aspects of tuberculosis in the child in Tunisia; results of the anti-tuberculosis campaign]. Alger.Medicale. 1951;55(3):725-49.

1. Kallander K, Nsungwa-Sabiiti J, Peterson S. Symptom overlap for malaria and pneumonia--policy implications for home management strategies. Acta Trop. 2004;90(2):211-4.
2. Mbonye AK. Risk factors for diarrhoea and upper respiratory tract infections among children in a rural area of Uganda. J.Health Popul.Nutr. 2004;22(1):52-8.
3. Mpabulungi L, Muula AS. Tobacco use among high shool students in Kampala, Uganda: questionnaire study. Croat.Med.J. 2004;45(1):80-3.
4. Olle-Goig JE. Drugs for MDR-TB in Uganda. Int.J.Tuberc.Lung Dis. 2004;8(2):271.
5. Tumwikirize WA, Ekwaru PJ, Mohammed K, Ogwal-Okeng JW, Aupont O. Management of acute respiratory infections in drug shops and private pharmacies in Uganda: a study of counter attendants' knowledge and reported behaviour. East Afr.Med.J. 2004;Suppl:S33-S40.
6. Watera C, Nakiyingi J, Miiro G, Muwonge R, Whitworth JA, Gilks CF et al. 23-Valent pneumococcal polysaccharide vaccine in HIV-infected Ugandan adults: 6-year follow-up of a clinical trial cohort. AIDS 2004;18(8):1210-3.
7. Elliott AM, Mawa PA, Joseph S, Namujju PB, Kizza M, Nakiyingi JS et al. Associations between helminth infection and CD4+ T cell count, viral load and cytokine responses in HIV-1-infected Ugandan adults. Trans.R.Soc.Trop.Med.Hyg. 2003;97(1):103-8.
8. Hladik W, Dollard SC, Downing RG, Kataaha P, Pellett PE, Karon JM et al. Kaposi's sarcoma in Uganda: risk factors for human herpesvirus 8 infection among blood donors. J.Acquir.Immune.Defic.Syndr. 2003;33(2):206-10.
9. Kikule E. A good death in Uganda: survey of needs for palliative care for terminally ill people in urban areas. BMJ 2003;327(7408):192-4.
10. Ramsay S. Leading the way in African home-based palliative care. Free oral morphine has allowed expansion of model home-based palliative care in Uganda. Lancet 2003;362(9398):1812-3.

1. Needham DM, Bowman D, Foster SD, Godfrey-Faussett P. Patient care seeking barriers and tuberculosis programme reform: a qualitative study. Health Policy 2004;67(1):93-106.
2. Guinness L, Walker D, Ndubani P, Jama J, Kelly P. Surviving the impact of HIV-related illness in the Zambian business sector. AIDS Patient.Care STDS. 2003;17(7):353-63.
3. Miti S, Mfungwe V, Reijer P, Maher D. Integration of tuberculosis treatment in a community-based home care programme for persons living with HIV/AIDS in Ndola, Zambia. Int.J.Tuberc.Lung Dis. 2003;7(9 Suppl 1):S92-S98.
4. Chintu C, Mudenda V, Lucas S, Nunn A, Lishimpi K, Maswahu D et al. Lung diseases at necropsy in African children dying from respiratory illnesses: a descriptive necropsy study. Lancet 2002;360(9338):985-90.
5. Godfrey-Faussett P, Kaunda H, Kamanga J, van Beers S, van Cleeff M, Kumwenda-Phiri R et al. Why do patients with a cough delay seeking care at Lusaka urban health centres? A health systems research approach. Int.J.Tuberc.Lung Dis. 2002;6(9):796-805.
6. Mwinga A, Hosp M, Zulu I, Farthing MJ, Mulambo S, Kelly P. Tuberculosis preventative treatment also prevented diarrhoea in HIV-infected patients in Zambia. AIDS 2002;16(5):806-8.
7. Mwinga A, Nunn A, Ngwira B, Chintu C, Warndorff D, Fine P et al. Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Lancet 2002;360(9339):1050-5.
8. Rosales FJ. Vitamin a supplementation of vitamin a deficient measles patients lowers the risk of measles-related pneumonia in zambian children. J.Nutr. 2002;132(12):3700-3.
9. Waddell RD, Lishimpi K, von Reyn CF, Chintu C, Baboo KS, Kreiswirth B et al. Bacteremia due to Mycobacterium tuberculosis or M. bovis, Bacille Calmette-Guerin (BCG) among HIV- positive children and adults in Zambia. AIDS 2001;15(1):55-60.
10. Godfrey-Faussett P, Mwinga A, Hosp M, Baggaley R, Quigley M, Porter J. Ethics and international research. Obtaining informed consent for trials in Africa is possible. BMJ 1998;316(7131):627-8.
11. Foster S, Godfrey-Faussett P, Porter J. Modelling the economic benefits of tuberculosis preventive therapy for people with HIV: the example of Zambia. AIDS 1997;11(7):919-25.
12. Buchan T. Primary tuberculosis in African children. Cent.Afr.J.Med. 1967;13(10):234-9.

1. Apers LM, Chihota V. Susceptibility of a series of routine sputum samples for antituberculosis chemotherapy in Gweru, Zimbabwe. S.Afr.Med.J. 2004;94(4):282.
2. Louie LG, Hartogensis WE, Jackman RP, Schultz KA, Zijenah LS, Yiu CH et al. Mycobacterium tuberculosis/HIV-1 coinfection and disease: role of human leukocyte antigen variation. J.Infect.Dis. 2004;189(6):1084-90.
3. Apers L, Mutsvangwa J, Magwenzi J, Chigara N, Butterworth A, Mason P et al. A comparison of direct microscopy, the concentration method and the Mycobacteria Growth Indicator Tube for the examination of sputum for acid-fast bacilli. Int.J.Tuberc.Lung Dis. 2003;7(4):376-81.
4. Gwanzura L, Pasi C, Nathoo KJ, Hakim J, Gangaidzo I, Mielke J et al. Rapid emergence of resistance to penicillin and trimethoprim-sulphamethoxazole in invasive Streptococcus pneumoniae in Zimbabwe. Int.J.Antimicrob.Agents 2003;21(6):557-61.
5. Mwaba P, Maboshe M, Chintu C, Squire B, Nyirenda S, Sunkutu R et al. The relentless spread of tuberculosis in Zambia--trends over the past 37 years (1964-2000). S.Afr.Med.J. 2003;93(2):149-52.
6. Gangaidzo IT, Moyo VM, Mvundura E, Aggrey G, Murphree NL, Khumalo H et al. Association of pulmonary tuberculosis with increased dietary iron. J.Infect.Dis. 2001;184(7):936-9.
7. Nathoo KJ, Gondo M, Gwanzura L, Mhlanga BR, Mavetera T, Mason PR. Fatal Pneumocystis carinii pneumonia in HIV-seropositive infants in Harare, Zimbabwe. Trans.R.Soc.Trop.Med.Hyg. 2001;95(1):37-9.
8. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000;84(2):183-8.
9. Warren CW, Riley L, Asma S, Eriksen MP, Green L, Blanton C et al. Tobacco use by youth: a surveillance report from the Global Youth Tobacco Survey project. Bull.World Health Organ 2000;78(7):868-76.
10. Mazengera LR, Nathoo KJ, Zegers BJ. Serum immunoglobulin levels in paediatric patients with pneumonia. Cent.Afr.J.Med. 1999;45(11):300-2.
11. Osim EE, Tandayi M, Chinyanga HM, Matarira HT, Mudambo KK, Musabayane CT. Lung function, blood gases, pH and serum electrolytes of small-scale miners exposed to chrome ore dust on the Great Dyke in Zimbabwe. Trop.Med.Int.Health 1999;4(9):621-8.
12. Shennan DH. Towards the rout of tuberculosis in Rhodesia. 3. Investigations and planning. Cent.Afr.J.Med. 1965;11(9):260-4.

Full listing